Dr. Mamounas on Neoadjuvant Chemotherapy for Breast Cancer

Eleftherios (Terry) P. Mamounas, MD
Published: Wednesday, Apr 11, 2018



Eleftherios (Terry) P. Mamounas, MD, medical director of the Comprehensive Breast Program at the University of Florida Health Cancer Center, discusses the management of neoadjuvant chemotherapy for patients with breast cancer.

Data has been accumulated over the last several years on the effects of neoadjuvant chemotherapy on down-staging the disease, not only in the breast but in the axilla. There are clinical trials demonstrating that neoadjuvant chemotherapy downstages the axillary nodes so it can confer positive nodes to negative nodes. Now physicians can offer sentinel lymph node biopsies, which can potentially turn patients away from having a dissection and reduce the risk of lymphedema and other morbidities.

Neoadjuvant chemotherapy not only reduces the disease burden but also the extent of axillary surgery, Mamounas says.
 
SELECTED
LANGUAGE


Eleftherios (Terry) P. Mamounas, MD, medical director of the Comprehensive Breast Program at the University of Florida Health Cancer Center, discusses the management of neoadjuvant chemotherapy for patients with breast cancer.

Data has been accumulated over the last several years on the effects of neoadjuvant chemotherapy on down-staging the disease, not only in the breast but in the axilla. There are clinical trials demonstrating that neoadjuvant chemotherapy downstages the axillary nodes so it can confer positive nodes to negative nodes. Now physicians can offer sentinel lymph node biopsies, which can potentially turn patients away from having a dissection and reduce the risk of lymphedema and other morbidities.

Neoadjuvant chemotherapy not only reduces the disease burden but also the extent of axillary surgery, Mamounas says.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual Paris Breast Cancer Conference™Dec 31, 20181.5
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x